Login / Signup

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Haralabos P KalofonosEmmanouil V DermitzakisGeorgia XiromerisiouDimitrios RallisPanagiotis SoldatosPantelis LitsardopoulosMichail Vikelis
Published in: Journal of clinical medicine (2023)
A precise phenotypic profiling with identification of pain characteristics consistent with peripheral and/or central sensitization might reliably predict the responsiveness to fremanezumab in migraine prophylaxis.
Keyphrases
  • chronic pain
  • pain management
  • neuropathic pain
  • single cell
  • cross sectional
  • clinical trial
  • spinal cord injury